Sir Target
21 September 2023
Welcome to new Director David HulcoopHelena Cornu
21 September 2023
From hibernation to neurodegeneration: how a cold-resistance protein is paving the way to dementia treatmentsHelena Cornu
15 August 2023
Meet Yakov Tsepilov, our new Genetics team leaderHelena Cornu
7 August 2023
Open Targets Platform 23.06 has been released!Sir Target
26 June 2023
Case study: Open Targets at your fingertips with RaycastHelena Cornu, Irene López Santiago
20 June 2023
Case study: Querying the Open Targets Platform using natural languageHelena Cornu
25 May 2023
Code breaking and the Human Genome ProjectIan Dunham
25 April 2023
A leading scientist in the sequencing of the human genome, Ian Dunham reflects on the early years of the Wellcome Sanger Institute.
How Emmanouil Metzakopian is finding gene targets to treat neurodegenerationHelena Cornu
5 April 2023
Manos Metzakopian discusses his latest research, in which the team validated KAT2B gene knockouts as neuroprotective against ER stress.
Provenance Metadata — towards reproducible researchManuel Bernal Llinares
22 March 2023
How the Open Targets Platform Integrates Gene Burden AnalysesIrene López Santiago
6 March 2023
Analysis and explanation of gene burden associations in the Open Targets Platform
Open Targets Platform 23.02 has been released!Sir Target
22 February 2023
How Open Targets is using Artificial Intelligence and Machine Learning to identify and prioritise drug targetsHelena Cornu
2 December 2022
Open Targets Platform 22.11 has been released!Sir Target
24 November 2022
Open Targets Genetics: version 8 is out!Sir Target
13 October 2022
Open Targets Platform 22.09 has been releasedSir Target
3 October 2022
Open Targets Platform 22.06 has been released!Sir Target
24 June 2022
Next steps in our web applications' architectureCarlos Cruz
21 June 2022
How Lorenzo Bomba is using rare genetic variants to understand blood metabolitesHelena Cornu
31 May 2022
Open Targets Platform 22.04 has been released!Sir Target
28 April 2022